Reducing Health Care Resource Utilization in COPD: A Retrospective Matched Control Analysis of a Digital Quality Improvement Program

Thomas Brazeal,Leanne Kaye,Vy Vuong,Jade Le,Zachary Peris,Meredith A Barrett

DOI: https://doi.org/10.15326/jcopdf.2024.0532

2024-09-06

Abstract:Introduction: COPD is a progressive lung disease that adds significant economic burden to the healthcare system in the United States. Digital platforms integrated into clinical workflows have demonstrated success in improving patient outcomes in COPD, but few studies have explored the impact of an integrated digital and clinical approach on drivers of direct healthcare costs (COPD-related prescriptions, emergency department (ED) visits and hospitalizations) in a real-world setting. Methods: We conducted a six-month retrospective matched control analysis to assess the impact of a digital quality improvement (QI) program delivered by clinical pharmacists on healthcare resource utilization among people living with COPD. Results: Compared to matched controls at six months, participants in the digital QI program had a nearly two-third relative reduction in COPD-related ED visits and hospitalizations (p=0.044), as well as a 47% reduction in all-cause ED visits and hospitalizations (p=0.059). Participants in the digital QI program also had higher rates of COPD-related prescription fills for antibiotics and oral corticosteroids, as well as a greater number of non-acute care visits compared to matched controls. Conclusion: Digital health platforms integrated into a virtual clinical pharmacist workflow can help reduce costly COPD-related emergency department visits and hospitalizations. Care models integrating digital platforms may also offer a scalable approach to managing COPD and should be explored in different clinical settings.